CircRNA-encoded RIPK1-98 protein drives lung adenocarcinoma progression
Developmental Cell · 2026-05 · 61 (5) · 1092-1110.e12
DOI: 10.1016/j.devcel.2026.02.014 ↗At a glance
Journal article in Developmental Cell, 2026-05. Written by Qi Sun and 13 co-authors. Institution: Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Shanghai …. Major MEDLINE topics: Adenocarcinoma of Lung, Lung Neoplasms, Receptor-Interacting Protein Serine-Threonine Kinases, RNA, Circular. 90 references.
Abstract (original language)
Unexplored biological matter-including uncharacterized genetic elements, molecular entities, and microbial components-remains poorly understood. Here, we use integrated multi-omics approaches to identify and characterize previously unrecognized protein products encoded by circular RNAs (circRNAs) in human tissue specimens and to delineate their roles in the progression of lung adenocarcinoma (LUAD). The transcription of precursor mRNA by RNA polymerase Ⅱ subunit A (RPB1) is crucial for the biogenesis of these potential circRNA-encoded proteins. Functional and translational analyses link their expression to distinct pathological stages of LUAD in patients. The protein RIPK1-98, encoded by circRIPK1, was identified as functionally distinct from its parental gene product, receptor-interacting serine/threonine kinase 1 (RIPK1). RIPK1-98 modulates cyclin-dependent kinase 2 (CDK2)-dependent cell-cycle regulation, thereby facilitating tumor proliferation in cellular and animal models. Together, these findings suggest that RIPK1-98 serves as a biomarker for cell-cycle progression in LUAD and highlight its potential as a therapeutic target to counteract resistance to first-line treatments, such as osimertinib.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai 200030, China.
- Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai 200030, China; B…
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris, France; Metabolomics and Cell Biology…
Cite
APA
Sun, Q., Chi, R., Zhang, X., Chen, T., Xu, X., Ma, L., Tian, X., Miao, Y., Yu, Y., Kang, R., Kroemer, G., Shi, Y., Tang, D., & Wang, J. (2026). CircRNA-encoded RIPK1-98 protein drives lung adenocarcinoma progression. Developmental Cell, 61(5), 1092-1110.e12. https://doi.org/10.1016/j.devcel.2026.02.014
Vancouver
Sun Q, Chi R, Zhang X, Chen T, Xu X, Ma L, et al. CircRNA-encoded RIPK1-98 protein drives lung adenocarcinoma progression. Developmental Cell. 2026;61(5):1092-1110.e12. doi:10.1016/j.devcel.2026.02.014
BibTeX
@article{Sun2026,
author = {Sun, Qi and Chi, Runqiu and Zhang, Xiao and Chen, Tianxiang and Xu, Xin and Ma, Lifang and Tian, Xiaoting and Miao, Yayou and Yu, Yongchun and Kang, Rui and Kroemer, Guido and Shi, Yi and Tang, Daolin and Wang, Jiayi},
title = {CircRNA-encoded RIPK1-98 protein drives lung adenocarcinoma progression},
journal = {Developmental Cell},
year = {2026},
volume = {61},
number = {5},
pages = {1092--1110.e12},
doi = {10.1016/j.devcel.2026.02.014}
}
EUVIMED